P-gp-IN-32
P-gp-IN-32 is a P-glycoprotein (P-gp) inhibitor. P-gp-IN-32 exhibits low cytotoxicity and potent multidrug resistance (MDR) reversal activity against Doxorubicin (HY-15142A) in MCF7/ADR cells (IC50 = 0.11 μM, reversal fold (RF) = 215.9). P-gp-IN-32 can bind to P-gp directly, induce a conformation change of P-gp and inhibit the efflux function. P-gp-IN-32 can be used for the research of cancer, such as breast cancer.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2918249-59-7
- 화학식: C35H34N2O5
- 분자량:562.65
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
P-gp-IN-32 (Compound BP3p) (5 μM) shows growth inhibition rates below 25% in both MCF-7 and MCF-7/ADR cells[1].
P-gp-IN-32 has a RF of 215.9 combined with Doxorubicin (HY-15142A) (IC50 of 0.11 μM) in MCF-7/ADR cells[1].
P-gp-IN-32 (2.5-5 μM, 4 h) increases Rhodamine 123 accumulation in MCF-7/ADR cells in a dose-dependent manner[1].
P-gp-IN-32 (0.5-5 μM, 48 h) has no significant effect on P-gp expression in MCF-7/ADR cells[1].
P-gp-IN-32 (50 μM) enhances UIC-2 antibody (HY-P990196) binding to P-gp in MCF-7/ADR cells[1].
P-gp-IN-32 (5 μM, 5 days) reduces the volume of MCF-7/ADR 3D tumor spheroids combined with Doxorubicin[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF-7/ADR cells
-
Concentration:0.5, 2.5 and 5 μM
-
Incubation Time:48 h
-
Result:Did not reduce P-gp expression.
Chemical Information
-
CAS No. 2918249-59-7
-
분자량 562.65
-
화학식 C35H34N2O5
-
SMILES
COC1=CC(C2=CC3=C(N(C(C(N4CCC5=C(C4)C=C(C(OC)=C5)OC)=O)=C3)CC6=CC=C(C=C6)OC)C=C2)=CC=C1
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)